ERBB2 and breast carcinoma: Approximately 20–30% breast cancers show 40–100 fold elevated levels of Her2, whereas other cancer types such as ovarian, endometrial, gastric and esophageal cancers were also detected with over-expressed Her2 protein levels65–71.